Loading Events

« All Events

  • This event has passed.

CRISPR: Dr. Max Gomez on Cells as the New Health Cure

May 21 @ 6:30 pm - 8:00 pm

TUESDAY, MAY 21
6:30PM WINE RECEPTION
7:00PM INTERVIEW
Free for members free; $15 for guests
Cures that were once considered science fiction only a few years ago are now a reality. CRISPR, a new technology for targeted gene editing to eliminate genetic diseases, utilizes living cells as treatment instead of traditional drugs, surgery or radiation. Dr. Max Gomez (’73), author of Cells Are the New Cure, will take us through cutting-edge medical breakthroughs and how human cells are promising treatments for cancer, heart disease, organ replacement and aging. Through regenerative medicine, doctors can repair injured and aging tissues and even create artificial body parts and organs in the lab. These new technologies make it possible to harness the immune system to fight cancer, reverse diseases like multiple sclerosis, type 1 diabetes and rheumatoid arthritis and alleviate the effects of strokes, Alzheimer’s disease and even allergies.

Dr. Gomez has produced award-winning health and science segments for network TV. Many know him as the medical reporter/health editor for WNBC and WCBS. The recipient of numerous journalism awards, he has received seven New York Emmy Awards, two Philadelphia Emmys, a UPI honor for Best Documentary for a report on AIDS and an Excellence in Time of Crisis Award from New York City after September 11. He was also named the American Health Foundation’s Man of the Year and was a NASA Journalist-In-Space Semi-Finalist in 1986. A native of Havana, Cuba, Dr. Gomez graduated cum laude from Princeton University, and earned his PhD from the Wake Forest University School of Medicine. He was also a NIH Postdoctoral Fellow at Rockefeller University.

Krista McKerracher, a seasoned biopharmaceutical leader, will interview Dr. Gomez. She is currently Vice President, Head of Hemoglobinopathy Programs at CRISPR Therapeutics. Her experience includes Novartis, where she was Vice President for Oncology Global Development, as well as Johnson & Johnson, where she was Executive Director, Ortho Clinical Diagnosis. McKerracher, a native of Canada, has a BSc (Hons) in Applied Health Studies from the University of Waterloo and an MBA from the Schulich School of Business at York University.

Details

Date:
May 21
Time:
6:30 pm - 8:00 pm